These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31472046)

  • 1. Serum cell-free DNA concentrations and integrity analysis of colorectal cancer patients before and after surgery.
    Cao G; Xie Y; Jiang X; Tian X; Wang D; Sun Y
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):44-51. PubMed ID: 31472046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free DNA as a biomarker for colorectal cancer: a retrospective analysis in patients before and after surgery.
    Zhong Y; Zhou Q; Zhang Y; Zhou S; Zhang G; Jiang C; Zhang Z; Zhang X; Xu J; Jin C; Cao L; Chen L
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):135-141. PubMed ID: 32415940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of cell-free DNA concentration and integrity in serum of gastric cancer patients before and after surgery.
    Zhang X; Wu Z; Shen Q; Li R; Jiang X; Wu J; Li D; Wang D; Zou C; Zhong Y; Cheng X
    Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):111-117. PubMed ID: 31880527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of serum cfDNA concentration and integrity before and after surgery in patients with lung cancer.
    Fan Y; Shi M; Chen S; Ju G; Chen L; Lu H; Chen J; Zheng S
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):56-63. PubMed ID: 31472048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of plasma cfDNA concentration and integrity in breast cancer patients.
    Miao Y; Fan Y; Zhang L; Ma T; Li R
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):64-72. PubMed ID: 31472049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of Efficacy Evaluation Comparison of cfDNA and CEA in Colorectal Cancer.
    Yu D; An G; Xu L
    Clin Lab; 2016 Oct; 62(10):1947-1953. PubMed ID: 28164530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
    Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
    Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The analysis of cell-free DNA concentrations and integrity in serum of initial and treated of lymphoma patients.
    Wu J; Tang W; Huang L; Hou N; Wu J; Cheng X; Ma D; Qian P; Shen Q; Guo W; Peng W; Liu Y; Jiang C; Feng J
    Clin Biochem; 2019 Jan; 63():59-65. PubMed ID: 30292543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Cell Free DNA Integrity Index as a Biomarker for Response to Chemotherapy in Patients with Metastatic Colorectal Carcinoma.
    Eskander NS; Mansour L; Abdelaal A; Saad E; Mohamed D
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):339-348. PubMed ID: 35092403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden.
    Bhangu JS; Taghizadeh H; Braunschmid T; Bachleitner-Hofmann T; Mannhalter C
    Surg Oncol; 2017 Dec; 26(4):395-401. PubMed ID: 29113658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of the concentration and integrity of serum cell-free DNA for the clinical diagnosis of esophageal carcinoma].
    Qiu YW; Shen XJ; Jin CJ; Cao XJ; Ju SQ
    Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):905-910. PubMed ID: 30605980
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma cfDNA for the Diagnosis and Prognosis of Colorectal Cancer.
    Wu Z; Yu L; Hou J; Cui L; Huang Y; Chen Q; Sun Y; Lu W; Zhang C; Sun D
    J Oncol; 2022; 2022():9538384. PubMed ID: 35685424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of cell-free DNA in gastrointestinal tract malignancy.
    Lan YT; Chen MH; Fang WL; Hsieh CC; Lin CH; Jhang FY; Yang SH; Lin JK; Chen WS; Jiang JK; Lin PC; Chang SC
    Oncotarget; 2017 Jan; 8(2):3009-3017. PubMed ID: 27936467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stage-dependent alterations in cell-free DNA in patients with colorectal cancer.
    Pu W; Xiao L; Zhou C; Zhong F; Wu Y; Gong W; Lv X; Zhuang Z; Wang H; Bian H; Wang J; Zhang R; Li K; Xing C
    J BUON; 2021; 26(1):109-115. PubMed ID: 33721440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cell-free DNA chromosomal instability analysis by low-pass whole-genome sequencing to monitor breast cancer relapse.
    Zhou H; Wang XJ; Jiang X; Qian Z; Chen T; Hu Y; Chen ZH; Gao Y; Wang R; Ye WW; Cao WM
    Breast Cancer Res Treat; 2019 Nov; 178(1):63-73. PubMed ID: 31364001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients.
    Tóth K; Patai ÁV; Kalmár A; Barták BK; Nagy ZB; Galamb O; Wichmann B; Tulassay Z; Molnár B
    Pathol Oncol Res; 2017 Jul; 23(3):699-706. PubMed ID: 28035516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of serum human tumor protein P53 in colorectal cancer combined diagnosis and postoperative monitoring].
    Fan P; Zhang Y; Deng F; Chen SH; Li M; Zhang Q
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2670-2673. PubMed ID: 28910954
    [No Abstract]   [Full Text] [Related]  

  • 19. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
    Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of combined testing of YKL-40 with CEA in Chinese colorectal cancer patients.
    Ye HM; Lu YZ; Liang XM; Lin YZ; Li Y; Zhang ZY; Tzeng CM
    Clin Lab; 2014; 60(3):397-405. PubMed ID: 24697115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.